Prognostic Value of EGFR Mutation and ERCC1 in Patients with Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy

BACKGROUND: In order to improve the outcome of patients with non-small cell lung cancer (NSCLC), a biomarker that can predict the efficacy of chemotherapy is needed. The aim of this study was to assess the role of EGFR mutations and ERCC1 in predicting the efficacy of platinum-based chemotherapy and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Yamashita, Fumie, Azuma, Koichi, Yoshida, Tsukasa, Yamada, Kazuhiko, Kawahara, Akihiko, Hattori, Satoshi, Takeoka, Hiroaki, Zaizen, Yoshiaki, Kawayama, Tomotaka, Kage, Masayoshi, Hoshino, Tomoaki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2013
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3734014/
https://ncbi.nlm.nih.gov/pubmed/23940741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0071356
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia